HK1041213A1 - 噻唑烷二酮衍生物用於防止早產或哺乳時子宮收縮的用途 - Google Patents

噻唑烷二酮衍生物用於防止早產或哺乳時子宮收縮的用途

Info

Publication number
HK1041213A1
HK1041213A1 HK02102806.8A HK02102806A HK1041213A1 HK 1041213 A1 HK1041213 A1 HK 1041213A1 HK 02102806 A HK02102806 A HK 02102806A HK 1041213 A1 HK1041213 A1 HK 1041213A1
Authority
HK
Hong Kong
Prior art keywords
lactation
uterine contractions
premature labour
preventing uterine
thiazolidinediones
Prior art date
Application number
HK02102806.8A
Other languages
English (en)
Inventor
J‧A‧科普蘭德三世
K‧L‧艾夫斯
M‧索羅夫
Original Assignee
德克薩斯大學董事會
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德克薩斯大學董事會 filed Critical 德克薩斯大學董事會
Publication of HK1041213A1 publication Critical patent/HK1041213A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HK02102806.8A 1998-10-29 2002-04-15 噻唑烷二酮衍生物用於防止早產或哺乳時子宮收縮的用途 HK1041213A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10613398P 1998-10-29 1998-10-29
PCT/US1999/025433 WO2000025781A1 (en) 1998-10-29 1999-10-29 Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation

Publications (1)

Publication Number Publication Date
HK1041213A1 true HK1041213A1 (zh) 2002-07-05

Family

ID=22309672

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02102806.8A HK1041213A1 (zh) 1998-10-29 2002-04-15 噻唑烷二酮衍生物用於防止早產或哺乳時子宮收縮的用途

Country Status (19)

Country Link
US (1) US7528133B1 (zh)
EP (1) EP1126844A1 (zh)
JP (1) JP2002528500A (zh)
KR (1) KR20010089381A (zh)
CN (1) CN1328456A (zh)
AU (1) AU1330800A (zh)
BR (1) BR9915820A (zh)
CA (1) CA2348910A1 (zh)
CZ (1) CZ20011524A3 (zh)
HK (1) HK1041213A1 (zh)
HU (1) HUP0104900A3 (zh)
ID (1) ID29352A (zh)
IL (1) IL142841A0 (zh)
MX (1) MXPA01004257A (zh)
NO (1) NO20012090L (zh)
PL (1) PL347508A1 (zh)
TR (1) TR200101882T2 (zh)
WO (1) WO2000025781A1 (zh)
ZA (1) ZA200103999B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004062563A2 (en) * 2003-01-16 2004-07-29 Université de Lausanne Methods for screening for therapeutic agents that are useful in the treatment of oxytocin and vasopressin-related disorders
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes
WO2014066568A1 (en) 2012-10-24 2014-05-01 Winthrop-University Hospital Non-invasive biomarker to identify subjects at risk of preterm delivery
US10555934B2 (en) * 2016-01-04 2020-02-11 ObsEva S.A. Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof
JP2020533595A (ja) 2017-09-13 2020-11-19 プロジェニティ， インコーポレイテッド 子癇前症バイオマーカならびに関連するシステムおよび方法
EP4070113A4 (en) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5370135A (en) * 1993-10-13 1994-12-06 Biex, Inc. Use of estriol measurement to monitor tocolytic therapy
TW438587B (en) 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EP0783888A1 (en) * 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
EP0844997A1 (en) * 1996-06-19 1998-06-03 Dr. Reddy's Research Foundation Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
US5814647A (en) * 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms

Also Published As

Publication number Publication date
TR200101882T2 (tr) 2001-12-21
US7528133B1 (en) 2009-05-05
KR20010089381A (ko) 2001-10-06
HUP0104900A2 (hu) 2002-04-29
NO20012090D0 (no) 2001-04-27
HUP0104900A3 (en) 2003-02-28
CN1328456A (zh) 2001-12-26
PL347508A1 (en) 2002-04-08
CZ20011524A3 (cs) 2002-01-16
EP1126844A1 (en) 2001-08-29
BR9915820A (pt) 2001-10-30
ZA200103999B (en) 2002-08-16
IL142841A0 (en) 2002-03-10
CA2348910A1 (en) 2000-05-11
JP2002528500A (ja) 2002-09-03
AU1330800A (en) 2000-05-22
ID29352A (id) 2001-08-23
MXPA01004257A (es) 2002-06-21
NO20012090L (no) 2001-06-27
WO2000025781A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
EP1124543A4 (en) REGULATED RELEASE FORMULATION FOR WATER-SOLUBLE DRUGS
HUP0202477A3 (en) Use of phthalazine derivatives
PL354783A1 (en) Extended release formulations of erythromycin derivatives
PL351261A1 (en) Derivatives of indigoid bisindoles
HUP0302046A3 (en) Neurotrophin production/secretion promoting agent containing azole derivatives
IL143407A0 (en) Controlled release formulation of divalproex sodium
AU2677899A (en) Polishing composition including water soluble polishing agent
IL147669A0 (en) Method for transdifferentiation of body tissues
EG23980A (en) Potassium salt of (s)-omeprazole
HUP0200441A3 (en) Tetrahydropyran derivatives and their use as therapeutic agents and process for preparation the compounds
HUP0104374A3 (en) Growth hormone releasing compounds and their antagonists for use for treatment of tumors
PL347508A1 (en) Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
EP1117431A4 (en) TREATMENT OF ACIDOSIS
AU6941598A (en) Disposable garment having improved fitness to body during use
HUP9902783A3 (en) Polymorph of zopolrestat monohydrate, process for it's preparation and therapical use of the same
HK1047687A1 (zh) 組織凝固的裝置
HUP0101177A3 (en) Use of glycogen for preparation of ophtalmic solutions
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
GB9917346D0 (en) Medicament for treating premature ejaculation
HUP0103309A3 (en) Novel salts of n-tert-butylhydroxylamine and preparation thereof
HUP9903997A3 (en) Hydraulic cement composition and use thereof
GB9911546D0 (en) Release of poorly soluble agents
HUP0201610A3 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
AU5679199A (en) Water soluble composition(s) and method for inhibiting residue formation during use of same
HUP0202614A3 (en) Use of thienopyrimidines